Henderson Jane

Chief Financial Officer

Henderson Jane has filed 15 SEC Form 4 filings (25 transaction rows) across 2 companies, including APGE, AKRO, with disclosures dating back to 2025. 15 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.

On the most recent filing, Henderson Jane is listed as Chief Financial Officer at Apogee Therapeutics, Inc. Inside the rolling window, Henderson Jane reported no open-market purchases and 13 open-market sales totaling $2.1M in APGE. The largest disclosed transaction in the window is a sale of 6,000 APGE shares on Jan 2, 2026, worth $449K.

Companies traded

Other insiders at APGE

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$2.1M

reported sales (SEC code S)

Companies

2

in the rolling window

Source
APGESale$164KMay 5SEC ↗
APGESale$180KApr 17SEC ↗
APGESale$170KApr 3SEC ↗
APGESale$170KMar 27SEC ↗
APGESale$140KMar 4SEC ↗
APGESale$132KFeb 4SEC ↗
APGESale$449KJan 6SEC ↗
APGESale$160KJan 6SEC ↗
APGESale$120KDec 23SEC ↗
APGESale$113KDec 5SEC ↗
APGESale$105KNov 28SEC ↗
APGESale$130KNov 14SEC ↗
APGESale$60KNov 13SEC ↗
Showing 1–13 of 13
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Henderson Jane made?

Henderson Jane has filed 15 SEC Form 4 filings (25 transaction rows) across 2 companies, including APGE, AKRO since 2025.

Which companies does Henderson Jane trade?

Henderson Jane has filed SEC Form 4 disclosures for 2 companies, including APGE, AKRO.

When was Henderson Jane's most recent SEC Form 4 filing?

Henderson Jane's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.

What is Henderson Jane's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Henderson Jane is listed as Chief Financial Officer.

What is Henderson Jane's total buy and sell value in the current window?

Inside the rolling retention window, Henderson Jane bought $0 and sold $2.1M based on SEC Form 4 filings.

What was Henderson Jane's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 6,000 APGE shares on 2026-01-02, worth $449K, per SEC Form 4 filings.